Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 428Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Phesgo

PharmaCompass

01

Brand Name : Phesgo

Pertuzumab, Trastuzumab, Hyaluronidase

arrow
The MedTech Conference
Not Confirmed

02

Brand Name : Phesgo

Pertuzumab, Trastuzumab, Hyaluronidase

arrow
The MedTech Conference
Not Confirmed

03

Brand Name : Phesgo

Pertuzumab, Trastuzumab, Hyaluronidase

arrow
The MedTech Conference
Not Confirmed

04

Brand Name : Phesgo

Pertuzumab, Trastuzumab, Hyaluronidase

arrow
The MedTech Conference
Not Confirmed

Brand Name : Phesgo

arrow
The MedTech Conference
Not Confirmed

Pertuzumab, Trastuzumab, Hyaluronidase

Main Therapeutic Indication : Oncology

Currency : USD

2024 Revenue in Millions : 1,917

2023 Revenue in Millions : 1,299

Growth (%) : 48

blank